Asa Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -20.74%
- Profit Growth 0.78%
- Ebitda 3.06%
- Net Worth 26.22%
- Total Assets 3.13%
About Asa Diagnostics
Asa Diagnostics Private Limited (ADPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 June 2015 (Nine years and eight months 19 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Karuppiah Jayaraj and Ashok Jayaraj serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900TN2015PTC100848
- Company No.
100848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Healthcare
What products or services does Asa Diagnostics Private Limited offer?
Asa Diagnostics Private Limited offers a wide range of products and services, including Integration Support Service, Systems Integrators.
Who are the key members and board of directors at Asa Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karuppiah Jayaraj  | Director | 09-Jun-2015 | Current |
| Ashok Jayaraj | Director | 09-Jun-2015 | Current |
Financial Performance of Asa Diagnostics.
Asa Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.74% decrease. The company also saw a slight improvement in profitability, with a 0.78% increase in profit. The company's net worth Soared by an impressive increase of 26.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asa Diagnostics?
In 2023, Asa Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Truwo Healthcare Logistics Private LimitedAshok Jayaraj is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asa Diagnostics?
Unlock and access historical data on people associated with Asa Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asa Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asa Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.